The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis

NCT04372615 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

116

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Encephalitis
Encephalitis

Interventions

DRUG: Inebilizumab
DRUG: Placebo

Sponsor

University of Utah